Cargando…

Non-invasive Assessment of Liver Fibrosis Regression in Patients with Chronic Hepatitis B: A Retrospective Cohort Study

INTRODUCTION: Non-invasive tests (NITs) have been alternative methods of liver biopsy for the cross-sectional assessment of liver fibrosis in patients with chronic hepatitis B (CHB). However, there are limited data on the longitudinal association between NITs and histological changes of liver fibros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Wei, Hu, Qiankun, Chen, Chong, Li, Weixia, Li, Qiang, Chen, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925624/ https://www.ncbi.nlm.nih.gov/pubmed/36520331 http://dx.doi.org/10.1007/s40121-022-00738-1

Ejemplares similares

FibroScan Predicts Liver Fibrosis Progression in Chronic HBV Infection Patients with No Clear Indication for Antiviral Therapy: A Retrospective Cohort Study
por: Xu, Wei, et al.
Publicado: (2023)

Evaluation of eLIFT for Non-invasive Assessment of Liver fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Virus Infection
por: Li, Qiang, et al.
Publicado: (2017)

The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease
por: Li, Qiang, et al.
Publicado: (2017)

Accuracy of FibroScan in analysis of liver fibrosis in patients with concomitant chronic Hepatitis B and nonalcoholic fatty liver disease
por: Li, Qiang, et al.
Publicado: (2020)

The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China
por: Li, Qiang, et al.
Publicado: (2016)

Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B
por: Ji, Dong, et al.
Publicado: (2021)

Impact of age on the diagnostic performances and cut-offs of APRI and FIB-4 for significant fibrosis and cirrhosis in chronic hepatitis B
por: Li, Qiang, et al.
Publicado: (2017)

An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir
por: Liu, Yi-Qi, et al.
Publicado: (2023)

Serum hepatitis B surface antigen levels predict insignificant fibrosis and non-cirrhosis in hepatitis B e antigen positive patients with normal or mildly elevated alanine transaminase levels
por: Li, Qiang, et al.
Publicado: (2017)

Complement C3 Facilitates Stratification of Stages of Chronic Hepatitis B and Signifies Development of Acute-on-Chronic Liver Failure in Acute Decompensated Cirrhosis
por: Chen, Chong, et al.
Publicado: (2023)

A Novel Non-invasive Model Based on GPR for the Prediction of Liver Fibrosis in Patients With Chronic Hepatitis B
por: Ding, Rongrong, et al.
Publicado: (2021)

A novel diagnostic algorithm to predict significant liver inflammation in chronic hepatitis B virus infection patients with detectable HBV DNA and persistently normal alanine transaminase
por: Li, Qiang, et al.
Publicado: (2018)

A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis B
por: Chen, Yaqiong, et al.
Publicado: (2020)

Retrospective Evaluation of Non-Invasive Assessment Based on Routine Laboratory Markers for Assessing Advanced Liver Fibrosis in Chronic Hepatitis B Patients
por: Wang, Zeyu, et al.
Publicado: (2022)

CHINAT-CD4 Score Predicts Transplant-Free Survival in Patients with Acute-on-Chronic Liver Failure
por: Huang, Chenlu, et al.
Publicado: (2023)

Development and Validation of a Non-invasive Model to Predict Liver Histological Lesions in Chronic Hepatitis B Patients With Persistently Normal Alanine Aminotransferase and Detectable Viremia
por: Hu, Qiankun, et al.
Publicado: (2022)

On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B
por: Chang, Xiu-Juan, et al.
Publicado: (2019)

Combatting Fibrosis: Exosome‐Based Therapies in the Regression of Liver Fibrosis
por: Chen, Li, et al.
Publicado: (2018)

A novel non-invasive index using AFP and APTT is associated with liver fibrosis in patients with chronic hepatitis B infection: a retrospective cohort study
por: Feng, Limin, et al.
Publicado: (2015)

Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study
por: Li, Qiang, et al.
Publicado: (2017)

A new dyslipidemia-based scoring model to predict transplant-free survival in patients with hepatitis E-triggered acute-on-chronic liver failure
por: Chen, Chong, et al.
Publicado: (2023)

Regression of liver fibrosis: evidence and challenges
por: Sun, Ya-Meng, et al.
Publicado: (2020)

Assessment of Hepatic Fibrosis Regression by Transient Elastography in Patients with Chronic Hepatitis B Treated with Oral Antiviral Agents
por: Kim, Ja Kyung, et al.
Publicado: (2014)

A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B
por: Chen, Yan, et al.
Publicado: (2019)

Quantification of liver fibrosis in chronic hepatitis B virus infection
por: Jieanu, CF, et al.
Publicado: (2015)

Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
por: Liao, Min-Jun, et al.
Publicado: (2022)

The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China
por: Huang, Dedong, et al.
Publicado: (2019)

The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C
por: Lee, Jia-Jung, et al.
Publicado: (2020)

Influence of Gender and Reproductive Factors on Liver Fibrosis in Patients With Chronic Hepatitis B Infection
por: Xiong, Ming, et al.
Publicado: (2019)

Gamma‐Glutamyl Transpeptidase‐to‐Platelet ratio predicts liver fibrosis in patients with concomitant chronic hepatitis B and nonalcoholic fatty liver disease
por: Luo, Jie, et al.
Publicado: (2022)

FibroScan Detection of Fatty Liver/Liver Fibrosis in 2266 Cases of Chronic Hepatitis B
por: He, Tingshan, et al.
Publicado: (2020)

Non-invasive assessment of liver fibrosis through FibroMeter in patients with chronic viral hepatitis B and C
por: Săndulescu, Oana, et al.
Publicado: (2014)

Performance of Non-invasive Blood Parameters for Ruling Out Significant Liver Fibrosis in Patients with Chronic Hepatitis B
por: Khare, Shivam, et al.
Publicado: (2020)

Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B
por: HUANG, RENGANG, et al.
Publicado: (2016)

GATA4 induces liver fibrosis regression by deactivating hepatic stellate cells
por: Arroyo, Noelia, et al.
Publicado: (2021)

The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis
por: Ding, Qian, et al.
Publicado: (2019)

Chronic hepatitis B virus and liver fibrosis: A mathematical model
por: Friedman, Avner, et al.
Publicado: (2018)

Serum metabolomic signatures discriminate early liver inflammation and fibrosis stages in patients with chronic hepatitis B
por: Huang, Haijun, et al.
Publicado: (2016)

Artificial liver support system therapy in acute-on-chronic hepatitis B liver failure: Classification and regression tree analysis
por: Huang, Kaizhou, et al.
Publicado: (2019)

Identification and Validation of Novel Serum Autoantibodies Biomarkers for Staging Liver Fibrosis in Patients With Chronic Hepatitis B
por: Qi, Saiping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v1ikd8ahtlnrqv1rcpdfnsuheg